NCT06402656

Brief Summary

The aim of the study is to compare a customized facemask for the treatment of Class III malocclusion in the prepubertal growing patient (patients between the ages of 5 and 12 years) versus a standard commercial facemask. Specifically, preference, pain, difficulty in sleeping, time of use, and possible complications for the two types of facemasks will be analyzed. This is a single-center, national, controlled, superiority, randomized, crossover, open-label study. Each patient will be treated with both the customized facemask and the standard commercial facemask. Each patient will wear one type of facemask for 2 months and the other type of facemask for the next 2 months. After 2 weeks and at the end of therapy with each of the facemask types, the patient, with the possible help of the parents, will have to answer a questionnaire about pain and difficulty sleeping and report any complications. In addition, after completing both phases (fourth month), the patient should indicate a preference for one of the two types of mask with which to complete therapy for an additional 6 months.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

4 months

First QC Date

May 2, 2024

Last Update Submit

July 30, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Questionnaire on the preference of the patient for one of the two types of face masks

    The primary endpoint is a questionnaire on the preference between the two types of face masks at the end of the second phase of therapy (4 months after delivery of the first face mask)

    4 months

Secondary Outcomes (4)

  • Pain reported by patients

    At 2 weeks and at 2 months after delivery of each of the 2 face masks

  • Difficulty in sleeping reported by patients

    At 2 weeks and at 2 months after delivery of each of the 2 face masks

  • Number of complications

    At 2 weeks and at 2 months after delivery of each of the 2 face masks

  • Total time wear

    At 2 months after delivery of each of the 2 face masks

Study Arms (2)

Customized facemask

EXPERIMENTAL
Device: Customized facemask

Standard facemask

ACTIVE COMPARATOR
Device: Standard facemask

Interventions

The customized face mask will be fabricated from a 3D digital image of the patient's face obtained by means of a 3D scanner. Such a scanner consists of 6 digital SLR cameras and software capable of processing a 3-D image of the patient's face exportable as an stl file.

Customized facemask

The standard facemask is the commercially available Petit standard facemask

Standard facemask

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 5 and 12 years;
  • Class III malocclusion, for which early orthopedic treatment with rapid maxillary expander and facemask is indicated.
  • signing of informed consent

You may not qualify if:

  • Cleft lip and/or palate.
  • Craniofacial syndromes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Malocclusion, Angle Class III

Condition Hierarchy (Ancestors)

MalocclusionTooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2024

First Posted

May 7, 2024

Study Start

September 1, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2026

Last Updated

July 31, 2024

Record last verified: 2024-07